Several clinical studies have demonstrated the potential value of CXCL13 in the early diagnosis of HIV-NHL [56,78] and have shown significantly elevated serum CXCL13 levels as early as 2.5 years before lymphoma diagnosis [79]. This evidence concerns the gene CXCL13 and non-Hodgkin lymphoma.